A detailed history of Farther Finance Advisors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 652 shares of MNKD stock, worth $3,579. This represents 0.0% of its overall portfolio holdings.

Number of Shares
652
Previous 7,396 91.18%
Holding current value
$3,579
Previous $27.7 Million 87.34%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$3.42 - $5.74 $23,064 - $38,710
-6,744 Reduced 91.18%
652 $3.5 Million
Q2 2025

Jul 11, 2025

BUY
$3.71 - $5.04 $25,584 - $34,755
6,896 Added 1379.2%
7,396 $27.7 Million
Q1 2025

Apr 14, 2025

BUY
$4.92 - $6.6 $2,460 - $3,300
500 New
500 $2.48 Million
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $217 - $278
65 New
65 $237,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.41B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.